sanofi-aventis

1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 535 432
Medical Information e-mail: uk-medicalinformation@sanofi-aventis.com

Patient Information Leaflet last updated on the eMC: 19/01/2012
PIL Telfast 30mg tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/01/2012 and displayed until Current
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 10/01/2011 and displayed until 19/01/2012
Reasons for adding or updating:
  • Change due to harmonisation of PIL.
Updated on 07/05/2009 and displayed until 10/01/2011
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 08/06/2004 and displayed until 07/05/2009
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 22/08/2003 and displayed until 08/06/2004
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
   fexofenadine hydrochloride